← Back to Discover
Bellevue Asset Management AG
Period ended Dec 31, 2015 · Latest filing Feb 12, 2016
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Dec 31, 2015: $656,311,000
More quarters will appear as history becomes available.
Top holdings
Top 10 at Dec 31, 2015. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Celgene Corporation · COM · 151020104 · shares: $26,037,000
- Biogen Inc. · COM · 09062X103 · shares: $25,743,000
- Gilead Sciences, Inc. · COM · 375558103 · shares: $24,298,000
- Amgen Inc. · COM · 031162100 · shares: $19,967,000
- Regeneron Pharmaceuticals, Inc. · COM · 75886F107 · shares: $19,760,000
- Medtronic, Inc. · COM · 585055106 · shares: $19,730,000
- Illumina, Inc. · COM · 452327109 · shares: $17,549,000
- Abbott Laboratories · COM · 002824100 · shares: $17,133,000
- Mylan Inc. · COM · 628530107 · shares: $17,048,000
- Becton, Dickinson and Company · COM · 075887109 · shares: $16,191,000
Filing totals differ
The filing summary reports $656,311,000, while the holdings entries total $656,313,000.
Reported holdings
127 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Alder Biopharmaceuticals Inc. | COM | 014339105 | — | 33,000 shares | $1,090,000 |
| Exelixis, Inc. | COM | 30161Q104 | — | 170,000 shares | $959,000 |
| Esperion Therapeutics Inc. | COM | 29664W105 | — | 40,000 shares | $890,000 |
| Abbvie Inc. | COM | 00287Y109 | — | 15,000 shares | $889,000 |
| Kite Pharma, Inc. | COM | 49803L109 | — | 14,000 shares | $863,000 |
| Ishares TR | NASDQ BIOTEC ETF | 464287556 | — | 2,500 shares | $846,000 |
| Affymetrix, Inc. | COM | 00826T108 | — | 80,000 shares | $807,000 |
| ResMed Inc. | COM | 761152107 | — | 15,000 shares | $805,000 |
| Insulet Corporation | COM | 45784P101 | — | 21,000 shares | $794,000 |
| Impax Laboratories, Inc. | COM | 45256B101 | — | 18,000 shares | $770,000 |
| Team Health Holdings Inc. | COM | 87817A107 | — | 15,000 shares | $658,000 |
| Myriad Genetics, Inc. | COM | 62855J104 | — | 14,000 shares | $604,000 |
| Arbutus Biopharm Corporation | COM | 03879J100 | — | 125,000 shares | $556,000 |
| Juniper Pharmaceuticals Inc. | COM | 48203L107 | — | 50,000 shares | $515,000 |
| Cadiovascular Systems Inc. | COM | 141619106 | — | 30,000 shares | $454,000 |
| MannKind Corporation | COM | 56400P201 | — | 300,000 shares | $435,000 |
| Immunomedics, Inc. | COM | 45253H101 | — | 30,000 shares | $407,000 |
| Endocyte, Inc. | COM | 29269A102 | — | 100,000 shares | $401,000 |
| Tenet Healthcare Corporation | COM NEW | 88033G407 | — | 10,000 shares | $303,000 |
| XOMA Corporation | COM | 98419J107 | — | 225,000 shares | $299,000 |
| Heartware International, Inc. | COM | 422368100 | — | 5,000 shares | $252,000 |
| Tetraphase Pharmaceuticals, Inc. | COM | 88165N105 | — | 22,000 shares | $221,000 |
| Geron Corporation | COM | 374163103 | — | 45,000 shares | $218,000 |
| Theravance Biopharma, Inc. | COM | G8807B106 | — | 11,428 shares | $187,000 |
| Celladon Corporation | COM | 15117E107 | — | 50,000 shares | $74,000 |
| Asterias Biotherapeutics, Inc. | COM SER A | 04624N107 | — | 1,875 shares | $7,000 |
| Biotime Inc. | W EXP 10/01/2018 | 09066L162 | — | 2,294 shares | $3,000 |